Is sirolimus-based immunosuppression associated with increased survival after liver transplantation for hepatocellular carcinoma?
According to these data, sirolimus-based immunosuppression has unique posttransplant effects on HCC patients that lead to improved survival.
Maternal family history of T2D had a more pronounced effect on the lipid parameters generally evaluated during health checkups than did paternal family history of T2D. Therefore, we recommend systematic screening for early detection and appropriate healthcare guidance for Japanese women, particularly those with maternal family history of T2D.